Idxg stock.
Interpace Biosciences Inc’s trailing 12-month revenue is $37.4 million with a -40.8% profit margin. Year-over-year quarterly sales growth most recently was -28.1%. There are not analysts providing consensus earnings estimates for the current fiscal year. Interpace Biosciences Inc does not currently pay a dividend.
Interpace Diagnostics Announces Launch of Enhancement to Thyroid Testing Services New Molecular Marker of Aggressiveness Being Added to ThyGenX Test Offering PRSep 30, 2023 · PARSIPPANY, NJ, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced financial results for the third quarter ended September 30, 2023 and provided a business and financial update. Third quarter Net Revenue was $9.1 million, a $0.9 million increase over third quarter 2022. On Wednesday, October 14, 2020, the Company, Interpace Biosciences, Inc., IDXG stock construct a change of 32.89 percent (↑ /The estimated Net Worth of Thomas W. Burnell is at least 437 千$ dollars as of 21 May 2021. Dr Burnell owns over 10,855 units of Interpace Biosciences Inc stock worth over 12,375$ and over the last 3 years he sold IDXG stock worth over 0$. In addition, he makes 425,004$ as Pres、 CEO & Director at Interpace Biosciences Inc.Interpace Biosciences Inc stock is down 4.75% over the past week and gets a Bullish rating from InvestorsObserver's Sentiment Indicator. Interpace Biosciences Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on IDXG!
6201 15th Avenue. Brooklyn, NY 11219. T: 718-921-8300. [email protected]. www.astfinancial.com. Interpace Biosciences® is a dynamic and growing leader in the life sciences industry, providing complex molecular analysis for the early diagnosis and treatment of cancer. Interpace Biosciences is a fully integrated commercial and ...
Parsippany, NJ, April 12, 2021 (GLOBE NEWSWIRE) -- Interpace Pharma Solutions, a subsidiary of Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) announced today new capability in advancing RNA biomarker analysis for gene and cell-based therapies. RNAscope ® in situ hybridization (ISH) is a new Interpace offering that …Find the latest Interpace Biosciences, Inc. (IDXG) stock quote, history, news and other vital information to help you with your stock trading and investing.
The 60 rating InvestorsObserver gives to Interpace Biosciences Inc stock puts it near the top of the Diagnostics & Research industry. In addition to scoring higher than 71 percent of stocks in the Diagnostics & Research industry, IDXG’s 60 overall rating means the stock scores better than 60 percent of all stocks.IDXG - Interpace Diagnostics Changes Name to Interpace Biosciences; Announces Plans for Next Phase of Growth and Third Quarter 2019 Financial Results. home / stock / idxg / idxg news. RSS . IDXG IDXG Quote IDXG Short IDXG News IDXG Articles IDXG Message Board. November, 13 2019 04:40 PM | GlobeNewswire | More on IDXG …It was because of IDXG stock I had 2021 which moved to OTC 2021 February 25. I got an alert on TD some time in March or April 3021 and within couple of days I sold it on April 5th. ... When I searched it is Tax payable on non-qualified income. The stock I have is FKWL. It is traded in nasdaq. So I don't know how is that non qualified investment ...[{"id":"11","charts":[{"sheetIndexNumber":-1,"components":[],"type":"ROW","tags":{},"chartData":[{"unit":"%","array":[{"Type":"NUMBER","Identifier":"SYNTH0","Year":"0 ...The estimated Net Worth of Thomas W. Burnell is at least $437 Mille dollars as of 21 May 2021. Dr Burnell owns over 10,855 units of Interpace Biosciences Inc stock worth over $11,723 and over the last 2 years he sold IDXG stock worth over $0. In addition, he makes $425,004 as Pres e CEO & Director at Interpace Biosciences Inc.
IDXG is the ticker symbol for Interpace Biosciences, Inc., a company that provides molecular diagnostic tests for cancer and other diseases. The stock price, news, quote and history of IDXG are shown on Yahoo Finance, as well as its performance outlook, earnings, dividends and research reports.
IDXG Stock Return DVA Stock Return ... We favor stocks that offer meaningfully greater expected return in the next 3 years; These returns are calculated based on our revenue forecast and Price to Sales Ratio (P/S) scenarios considered; Similar Price To Sales Ratio (P/S) scenarios are considered for both stocks and each scenario is weighted ...
6201 15th Avenue. Brooklyn, NY 11219. T: 718-921-8300. [email protected]. www.astfinancial.com. Interpace Biosciences® is a dynamic and growing leader in the life sciences industry, providing complex molecular analysis for the early diagnosis and treatment of cancer. Interpace Biosciences is a fully integrated commercial and ...Find the latest Research Frontiers Incorporated (REFR) stock quote, history, news and other vital information to help you with your stock trading and investing.IDXG | Complete Interpace Biosciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Today's Market. A high-level overview of Interpace Biosciences, Inc. (IDXG) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, …Find the latest Research Frontiers Incorporated (REFR) stock quote, history, news and other vital information to help you with your stock trading and investing.
Stock Screener. All earnings call transcripts on Interpace Biosciences, Inc. (IDXG) stock. Read or listen to the conference call. Download the investor presentation - earnings call slides.Interpace Biosciences Inc (OTC:IDXG) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds (or held) more ...The stock price for . Interpace Biosciences (OTCQX: IDXG) is $1.08 last updated November 14, 2023 at 12:47 PM UTC. Q Does Interpace Biosciences (IDXG) pay a dividend? The estimated Net Worth of Thomas W. Burnell is at least $438 mil dollars as of 21 May 2021. Dr Burnell owns over 10,855 units of Interpace Biosciences Inc stock worth over $12,917 and over the last 3 years he sold IDXG stock worth over $0. In addition, he makes $425,004 as Pres y CEO & Director at Interpace Biosciences Inc.Feb 10, 2016 · Interpace Biosciences Inc. (IDXG) Message Board - Company Name: Interpace Biosciences Inc., Stock Symbol: IDXG, Industry: Medical - Healthcare - Total Posts: 2811 - Last Post: 07/11/2023 09:52:18 AM - company/specific stock board Overview News Ideas Financials Technicals IDXG chart Today −5.88% 5 days 14.27% 1 month −20.00% 6 months 20.75% Year to date −13.51% 1 year −45.14% 5 years …
PARSIPPANY, NJ, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced financial results for the third quarter ended ...
In-Network Access for More Than 3 Million Members. Parsippany, NJ, March 10, 2020 (GLOBE NEWSWIRE) -- Interpace Diagnostics, a subsidiary of Interpace Biosciences (NASDAQ: IDXG) announced today that it has entered into a contract with Blue Cross Blue Shield of Massachusetts with over 3 million members in Massachusetts and across New …idxg stock quote. ⬇ Download stock pictures of Minions on Depositphotos Photo stock for commercial use - millions of high-quality, royalty-free photos & images ...© Valve Corporation. All rights reserved. All trademarks are property of their respective owners in the US and other countries. #footer_privacy_policy | #footer ...Dr D IDXG stock SEC Form 4 insiders trading. Dr has made over 1 trades of the Interpace Biosciences Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he bought 10,855 units of IDXG stock worth $94,221 on 21 May 2021.10,855 units of IDXG stock worth $94,221 on 21 May 2021.Aug 17, 2020 · Interpace Biosciences Inc (IDXG) stock is down -31.64% while the S&P 500 is up 0.35% as of 2:31 PM on Monday, Aug 17. IDXG is down -$1.83 from the previous closing price of $5.78 on volume of 968,030 shares. Over the past year the S&P 500 has risen 15.77% while IDXG is down -47.33%. IDXG lost -$8.53 per share the over the last 12 months. Log In – – % – – % – – % – – % – – % – – % Data & APIsInterpace Biosciences on Wednesday said it had closed the sale of its pharma services business to Flagship Biosciences.IDXG CEO Thomas Burnell said with the completion of the deal, the company's ...NASDAQ Health Care/Life Sciences Compare to Open 0.90 Prior Close 1.00 (11/07/23) 1 Day IDXG -5.00% DJIA 0.17% Russell 2K -0.28% Health Care/Life Sciences 1.90% …
Discover historical prices for IDXG stock on Yahoo Finance. View daily, weekly or monthly format back to when Interpace Biosciences, Inc. stock was issued.
Interpace Biosciences GAAP EPS of -$0.53, revenue of $10.38M. SA NewsMon, May 16, 2022 1 Comment.
Latest IDXG News. Track Interpace Biosciences Inc (IDXG) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your …Interpace Biosciences Inc. analyst ratings, historical stock prices, earnings estimates & actuals. IDXG updated stock price target summary. Stock Price Forecast The 1 analysts offering 12-month price forecasts for Interpace Biosciences Inc have a median target of 11.00, with a high estimate of 11.00 and a low estimate of 11.00.Dec 1, 2023 · Discover the top 3 undervalued Managed Health care stocks for Monday, November 20 based on AAII’s Stock Grades. Eunice Kim. Stock Grade Focus Is Interpace Biosciences Inc (IDXG) Stock a Good Investment? Nov 17, 2023 · finance.yahoo.com - July 10 at 8:15 PM. Interpace Expects to Stop Offering PancraGEN® Test Due to CMS Decision to End Reimbursement as of July 17, 2023. finance.yahoo.com - June 5 at 4:41 PM. Interpace Biosciences, Inc.: Interpace Biosciences Announces Record First Quarter 2023 Financial and Business Results. A solid price increase over a period of 12 weeks reflects investors' continued willingness to pay more for the potential upside in a stock. IDXG is quite a good fit in this regard, gaining 42.5% ...Interpace Biosciences, Inc. (NASDAQ:IDXG) released its earnings results on Wednesday, November, 8th. The business services provider reported ($0.12) EPS for the quarter. The business services provider had revenue of $9.08 million for the quarter.Interpace Biosciences Inc. (IDXG) Message Board - Company Name: Interpace Biosciences Inc., Stock Symbol: IDXG, Industry: Medical - Healthcare - Total Posts: 2811 - Last Post: 07/11/2023 09:52:18 AM - company/specific stock boardIn-Network Access for More Than 3 Million Members. Parsippany, NJ, April 27, 2020 (GLOBE NEWSWIRE) -- Interpace Biosciences (NASDAQ: IDXG) announced today that its subsidiary, Interpace Diagnostics, has entered into a contract with Avalon Healthcare Solutions (Avalon), a specialty benefit management company with more than …
Latest IDXG News. Track Interpace Biosciences Inc (IDXG) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your …Interpace Biosciences Stock Price, News & Analysis (NASDAQ:IDXG) Notice: This company has been marked as potentially delisted and may not be actively …Top Analyst Stocks Top Smart Score Stocks Top Insiders Stocks. Popular. Stock Screener Top Online Growth Stocks Trending Stocks Penny Stock Screener. Dividend Investing. Best Dividend Stocks Best High Yield Dividend Stocks Dividend Stock Comparison Dividend Calculator Dividend Returns Comparison. ETFs. ETF Center ETF …Instagram:https://instagram. bmo investorline accessbest public reitsbest time to buy stockex dividend date Interpace Diagnostics to Present New Data in Six Posters Related to PancraGEN™ at Upcoming Annual DDW International Meeting on May 6-9, 2017 PR Newswire ipo datestocks ex dividend Dr D IDXG stock SEC Form 4 insiders trading. Dr has made over 1 trades of the Interpace Biosciences Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he bought 10,855 units of IDXG stock worth $94,221 on 21 May 2021.10,855 units of IDXG stock worth $94,221 on 21 May 2021.٦ جمادى الآخرة ١٤٣٩ هـ ... IDXG signed a new national contract with Aetna for its ThyGenX ... to a particular stock represents solely the analyst's view of how that stock ... qualcoom stock idxg stock quote. ⬇ Download stock pictures of Minions on Depositphotos Photo stock for commercial use - millions of high-quality, royalty-free photos & images ...Interpace Biosciences Inc. 1.05. Delayed Data. As of Nov 21. -0.09 / -7.89%. Today’s Change. 0.51. Today ||| 52-Week Range. 3.54. Berikut daftar saham yang masuk IDX Growth 30 periode 11 Mei 2022 - 2 Agustus 2022 (Evaluasi Minor) : PT ACE Hardware Indonesia Tbk - ACES. PT Adaro Energy Indonesia Tbk - ADRO. PT Aneka Gas Industri Tbk - AGII. PT Aneka Tambang Tbk - ANTM. PT Bank Central Asia Tbk - BBCA.